Clexane 60 Mg 2 Syringe

Clexane 60 Mg 2 Syringe

Description:

Clexane 60 mg 2 Syringe is a prescription anticoagulant medicine containing enoxaparin sodium, a low molecular weight heparin (LMWH). It is supplied as prefilled syringes for subcutaneous injection and is used to prevent and treat blood clots (thromboembolic disorders) in adults. By reducing the formation of harmful clots in the veins and arteries, Clexane helps lower the risk of deep vein thrombosis (DVT), pulmonary embolism, and clot-related complications in certain heart conditions and after surgery. This product is intended for use under medical supervision only.

Indications:

• Prevention of deep vein thrombosis (DVT), especially in patients undergoing orthopedic or general surgery, or in bedridden medical patients at risk of clot formation.
• Treatment of established deep vein thrombosis with or without pulmonary embolism, as prescribed by a physician.
• Prevention of thromboembolic complications in patients with unstable angina or non–ST-elevation myocardial infarction (NSTEMI), as part of standard therapy (when indicated by a cardiologist).
• Prevention of clot formation in certain high-risk medical conditions where the doctor recommends low molecular weight heparin.
• Helps reduce symptoms and complications related to blood clots, such as leg pain, swelling, and risk of pulmonary embolism.

Active Ingredients / Key Components:

• Enoxaparin sodium – 60 mg per prefilled syringe (concentration commonly 100 mg/ml; exact volume per syringe corresponds to 60 mg dose).
• Other excipients: The full list of inactive ingredients (excipients) is not available in the provided information. Refer to the official package leaflet for complete details.

Dosage & Administration / How to Use:

• Clexane 60 mg is administered by subcutaneous injection only, usually into the fatty tissue of the abdomen or thigh. Do not inject into muscle.
• The exact dose, frequency, and duration are determined by the treating physician based on body weight, indication (prevention or treatment), kidney function, and overall clinical condition.
• For prophylaxis of DVT in moderate-risk patients, dosing is typically once daily; for treatment of established thrombosis or certain cardiac conditions, dosing may be once or twice daily according to medical advice. Always follow your doctor’s prescription.
• Wash hands before use. Clean the injection site with an antiseptic swab and allow to dry.
• Gently pinch a fold of skin between thumb and forefinger, insert the needle at a 90° or 45° angle (as instructed by your healthcare provider), and inject the full contents of the prefilled syringe slowly.
• Do not rub the injection site after administration to reduce the risk of bruising.
• Rotate injection sites with each dose to minimize local irritation.
• Do not expel the air bubble from the prefilled syringe before injection unless specifically instructed by your healthcare professional.
• Use each syringe only once and safely discard it in a sharps container. Do not reuse needles or syringes.
• Use with or without food, as food intake does not affect its action (it is not taken orally).

Clinical Benefits:

• Provides effective anticoagulation to help prevent the formation of dangerous blood clots in veins and arteries.
• Reduces the risk of deep vein thrombosis and pulmonary embolism, especially after surgery or during periods of prolonged immobilization.
• Supports management of certain acute coronary syndromes (such as unstable angina and NSTEMI) by lowering clot-related complications when used as part of standard therapy.
• Offers more predictable anticoagulant response compared to unfractionated heparin, often without the need for routine coagulation monitoring in most patients (as determined by the physician).
• Prefilled syringe format ensures accurate dosing and convenient administration in hospital or at home under medical guidance.

Warnings & Contraindications:

• Contraindicated in patients with known hypersensitivity to enoxaparin sodium, other low molecular weight heparins, heparin, or any component of the formulation.
• Contraindicated in patients with uncontrolled active bleeding or conditions with a high risk of major bleeding.
• Contraindicated in patients with a history of heparin-induced thrombocytopenia (HIT) unless specifically evaluated and cleared by a specialist.
• Use with extreme caution in patients with severe kidney impairment, liver disease, bleeding disorders, recent stroke, uncontrolled hypertension, or recent surgery involving the brain, spine, or eyes.
• May interact with other medicines that affect blood clotting, such as aspirin, nonsteroidal anti-inflammatory drugs (NSAIDs), other anticoagulants (warfarin, DOACs), antiplatelet agents, and thrombolytics. Inform your doctor about all medicines and supplements you are taking.
• Consult your doctor before use if pregnant or planning pregnancy. Enoxaparin is sometimes used in pregnancy under strict medical supervision. Do not start or stop treatment without medical advice.
• If breastfeeding, consult your doctor before use to evaluate risks and benefits.
• Use with caution in elderly patients, those with low body weight, or those at increased risk of falls or trauma.
• Do not self-inject unless you have been properly trained by a healthcare professional.
• Seek immediate medical attention if you notice signs of severe bleeding (unusual bruising, black stools, blood in urine, prolonged bleeding from cuts, coughing or vomiting blood).
• Keep out of reach of children.
• Not intended to diagnose, treat, cure, or prevent any disease without proper medical supervision. It is a prescription-only medicine and must be used strictly according to your doctor’s instructions.

Side Effects:

• Common side effects: Mild bruising, pain, redness, or irritation at the injection site; small hematomas under the skin; mild bleeding from gums or nose in some patients.
• Less common side effects: Elevated liver enzymes (usually reversible), allergic skin reactions such as rash, itching, or hives.
• Serious side effects (seek immediate medical attention): Severe or unexplained bleeding; black or tarry stools; blood in urine; coughing or vomiting blood; severe headache or dizziness; sudden weakness or numbness (possible stroke); chest pain or shortness of breath; signs of spinal/epidural hematoma (back pain, numbness, tingling, muscle weakness, loss of bladder or bowel control) especially if used with spinal or epidural anesthesia.
• Heparin-induced thrombocytopenia (HIT): Rare but serious drop in platelet count associated with increased risk of thrombosis. Your doctor may monitor blood counts if clinically indicated.
• If you experience any unusual symptoms or suspect an adverse reaction, contact your doctor or pharmacist immediately.

Storage Instructions:

Store in a cool, dry place away from direct sunlight. Do not freeze. Keep the prefilled syringes in their original packaging to protect from light and physical damage. Keep container tightly closed and out of reach of children. Do not use after the expiry date printed on the pack. Do not use if the solution is discolored, contains particles, or if the syringe is damaged.

Specifications:

• Form: Prefilled syringes for subcutaneous injection.
• Strength: 60 mg enoxaparin sodium per syringe.
• Pack size: 2 prefilled syringes.
• Route of administration: Subcutaneous (under the skin) only.
• Active ingredient: Enoxaparin sodium, a low molecular weight heparin anticoagulant.

Disclaimer:
All pharmacy products are intended for general use only and do not replace professional medical advice, diagnosis, or treatment. Always consult a healthcare provider before use. Results may vary, and no specific outcomes are guaranteed. Products are not intended to diagnose, treat, cure, or prevent any disease unless stated. Follow label instructions carefully, as misuse may cause adverse effects. Compliance with local laws is the customer’s responsibility.